3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
4
Lung Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
HRD Cancer
1
Colorectal Neoplasms
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Nivolumab
6
atezolizumab
5
Cisplatin
5
Ipilimumab
4
Carboplatin
4
Etoposide
3
pembrolizumab
2
gallium Ga 68 dotatate
2
dostarlimab
2
Temozolomide
2
Positron Emission Tomography Computed Tomography
2
Paclitaxel
2
Magnetic Resonance Imaging
2
Irinotecan
2
Immunoglobulin G
2
IFL protocol
2
Fluorouracil
2
Disulfides
2
zimberelimab
1
tivozanib
1
repotrectinib
1
niraparib
1
lutetium Lu 177 dotatate
1
lenvatinib
1
iadademstat
1
durvalumab
1
cabozantinib
1
budigalimab
1
belinostat
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Neuroendocrine
×
berzosertib
×
1 year
×
Clear all
No trials found.